A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

Also called NCT02750410

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 159 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02750410
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02750410. Randomized; double masking; primary purpose treatment. Start 2016-08 (registry gives no type); primary completion 2018-06-18 (actual). Results posted on 2019-09-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Intervention (Drug)
Dulaglutide
Intervention (Drug)
Placebo
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct02750410
Content hash
e8d6c930c6679db7af5904231dca29fb52454cf3a31171e4dbe316e23b507745